CANCER HARBORING BRAF ALTERATIONS

Clinical trials for CANCER HARBORING BRAF ALTERATIONS explained in plain language.

Never miss a new study

Get alerted when new CANCER HARBORING BRAF ALTERATIONS trials appear

Sign up with your email to follow new studies for CANCER HARBORING BRAF ALTERATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New targeted pill aims to shrink tough tumors with specific genetic flaw

Disease control Recruiting now

This study is testing an oral drug called plixorafenib (FORE8394) for people with advanced solid tumors or brain tumors that have specific changes in a gene called BRAF. The main goal is to see if the drug can shrink tumors and is safe for patients, including adults and children …

Matched conditions: CANCER HARBORING BRAF ALTERATIONS

Phase: PHASE2 • Sponsor: Fore Biotherapeutics • Aim: Disease control

Last updated Mar 17, 2026 12:55 UTC

CANCER HARBORING BRAF ALTERATIONS

Get alerted when new CANCER HARBORING BRAF ALTERATIONS trials appear

New targeted pill aims to shrink tough tumors with specific genetic flaw